Cite
APA Citation
Chen, W., Zeng, D., Desai, A., Badillo, M., Feng, L., Yan, F., Nomie, K., Ping, L., Ye, H., Liang, Y., Lee, H., Oki, Y., Romaguera, J., & Wang, M. (n.d.). improved outcome for patients with relapsed/refractory mantle cell lymphoma (MCL) who stop ibrutinib +/− rituximab for reasons other than progression of disease. Hematological oncology, 35, 360. http://access.bl.uk/ark:/81055/vdc_100047467523.0x00002a